Welcome to BiogenTalks and Multiple Dialogues of MS. Podcasts are intended for Healthcare Professionals only. Please do not share or distribute. This podcast series contains interviews with some of the world-leading experts in Multiple Sclerosis. In each episode you will receive useful information and advice on important themes and relevant questions.
Walking impairment in Multiple Sclerosis (MS): Symptoms, evaluation, and the role of exercise.
Walking impairment in Multiple Sclerosis (MS): The latest research.
Sequencing therapies in Multiple Sclerosis: Opportunities and strategic thinking.
Sequencing therapies in Multiple Sclerosis: Managing patients throughout the disease journey.
MS treatment in the era of COVID-19 (part 1): Disease management, virtual consultations and the global data sharing initiative.
MS treatment in the era of COVID-19 (part 2): Immunology, vaccination readiness and the upcoming flu season.
Understanding the effects of MS treatment with patient-reported outcomes (PROs).
Personalized medicine in multiple sclerosis (MS).
Pearls and pitfalls of real-world evidence (RWE).
How can we improve real-world data collection in multiple sclerosis (MS)?
What does the future in RWE look like?
Nursing strategies to improve MS patients´ adherence and persistence.
Key Learnings from up to 13 years of follow-up with TECFIDERA® (dimethyl fumarate) treatment experience.
Safety data from up to 13 years of long-term follow-up with TECFIDERA® (dimethyl fumarate) treatment.
Date of preparation: May 2021.